We studied brain energy metabolism by phos
phorus magnetic resonance spectroscopy e1p MRS) in 28 patients with mitochondrial cytopathies, and 20 normal control subjects. Fourteen patients had myopathy alone, six had only mild brain symptoms, and eight showed dif ferent degrees of brain involvement. Brain 31p MRS showed a low phosphocreatine content in all patients, accompanied by a high inorganic phosphate in 14 of 28 patients. The average value of the Pi concentration in the patient group was significantly (p = 0.009) different from the control group. The cytosolic pH was normal. From these data were derived a high concentration of ADP (cal-Mitochondrial cytopathies are a heterogeneous group of diseases thought to be due to inherited disorders of mitochondrial function (Schneck et aI., 1973; Berenberg et aI., 1977; Di Mauro et aI., 1985) , and characterized by a wide variety of clinical phe notypes (Schneck et aI., 1973; Berenberg et aI., 1977; Pavlakis et aI., 1984; Di Mauro et aI., 1985; Hurko and McKann, 1985; Bourd et aI., 1987; Frackowiak et aI., 1988; Wallace et at., 1988; Berk ovic et aI., 1989) . Many patients show symptoms and signs involving multiple organs as in Kearns Sayre syndrome (KSS), in myoclonic epilepsy and culated from the creatine kinase equilibrium), a high per cent value of V/V max for ATP biosynthesis, and a low phosphorylation potential, all features showing a de rangement of brain energy metabolism, in all patients with mitochondrial cytopathies. 31p MRS proved to be sensitive enough to disclose a deficit of mitochondrial functionality not only in the affected patients, but also in those without clinically evident brain symptoms. Key Words: Brain bioenergetics-Impaired brain energy me tabolism-Mitochondrial cytopathies-Brain MR spec troscopy.
ragged-red fibers (MERRF), and the syndrome of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), while others appear to be clinically affected only in the extraoc ular muscles as in chronic progressive external oph thalmoplegia (CPEO) or do not show any muscle involvement as in Leber's hereditary optic neurop athy (LHON).
It has been recently shown that patients with LHON (Cortelli et aI., 1991) have a subclinical in volvement of skeletal muscles. It remains contro versial whether the brain of patients with different mitochondrial cytopathies may also (Eleff et aI., 1990; Matthews and Arnold, 1990; Matthews et aI., 1991; Montagna et aI., 1992) have a deficit of energy metabolism independently of the presence of brain symptoms.
At the moment, phosphorus magnetic resonance spectroscopy e1p MRS) is the only noninvasive method that allows an in vivo assessment of brain energy metabolism by measuring the high-energy phosphates.
The aim of this work was to ascertain by 31p MRS whether an impairment of brain energy metabolism was present in patients with mitochondrial cytopa thies, especially in those without any overt symp toms or signs of brain involvement. involvement of the limbs; within this CPEO group, pa tients 10 to 12 had additional symptoms and signs of CNS involvement, as manifested by psychic, cerebellar, or brain computed tomographic (CT) changes. Ragged-red fibers, the hallmark of mitochondrial alterations on mus cle biopsy, were prominent in these CPEO patients, in some cases associated with mtDNA deletions. Patients 13 to 18 all had familial LHON, in cases 13 to 17 linked to an 11 ,778 mtDNA mutation. Patients 19 to 23 were instead cases of mitochondrial myopathy (MM) unassociated with CPEO, and patients 24 to 28 were cases of mitochon drial encephalopathies (EM) with variable phenotypes [migrainous strokes and mtDNA deletion in case 24;
MATERIALS AND METHODS

Patients and control subjects
The patient group (Table 1) consisted of 28 patients affected by mitochondrial cytopathies. Patients 1 to 12 had CPEO, isolated or associated with mild myopathic heteroplasmy) cerebellar and brainstem atrophy; polyneuropathy CPEO = chronic progressive external ophthalmoplegia; LHON = Leber's hereditary optic neuropathy; MERRF = myoclonic epilepsy and ragged-red fibers; MELAS = mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes; MTRP = mitochondrial retinitis pigmentosa (Holt et aI., 1990) EM = encephalomyopathy; MM = mitochondrial myopathy; RRF = ragged-red fibers; HSL = high serum lactate; CK = serum creatine kinase; COX = cytochrome oxidase; SCR = succinate-cytochrome C reductase; SDH = succinate dehydrogenase; LE = lower extremities; EMG = electromyography; mtDNA = mitochondrial DNA.
MERRF and MELAS syndrome in cases 25 and 26, re spectively; and familial mitochondrial retinitis pigmento sa (Holt et al., 1990) in cases 27 and 28]. These patients, except case 27, had severe CNS involvement, as mani fested. in ischemic strokes, seizures, cerebellar, and brainstem atrophy. All patients were free from medica tions.
Normal control subjects, matched for age and sex, free from any neurological disorder, volunteered for the study.
Informed consent was obtained in all cases.
Phosphorus magnetic resonance spectroscopy 31p MR spectra were acquired by a GE 1.5 T Signa system with a spectroscopy accessory using a surface coil provided by General Electric (Milwaukee, WI, U.S.A.) as recently reported (Barbiroli et al., 1992) . The pulse width and transmitter power were adjusted to obtain max imal signal intensity. A data table of 1,000 complex points was collected for each free induction decay (FID). The band width was 2 kHz. The stimulation-response se quence was repeated every 5 s. The spectroscopic measurements were performed ac cording to the quantification and quality assessment pro tocols defined by the EEC Concerted Research Project on "Tissue Characterization by MRS and MRI," COMAC-BME 11. 1.3.
All studies were performed on occipital lobes by the depth-resolved surface-coil spectroscopy (DRESS) local ization technique (Bottomly et al., 1984) . The surface coil (with a test tube filled with water in the center) was placed directly on the skull in the occipital region and precisely positioned by imaging the brain as previously reported (Barbiroli et al., 1990) . The profile of the sensi tivity volume of the coil (Barbiroli et al., 199 1; Keevil et al., 199 1) was routinely overlapped to the proton image of the brain to avoid contamination by muscle resonances. The flip angle in the selected volume was approximately 30°, and it was not necessary to introduce any correction for saturation effects due to repetition time. Four hundred FIDs were accumulated to obtain a signal-to-noise ratio for j3-ATP of 9-12. The accumulated spectra were trans ferred to the data station and processed using 4 Hz line broadening and manual phasing. The baseline distortion due to the technique itself was removed by the method of Allman et al. (1989) . To quantify the individual compo nents, a curve-fitting program supplied with the Nicolet data station (RUN GENCAP) was used, assuming a Lorentzian line shape, and using a 14-line parameter anal ysis as previously described (Barbiroli et aI., 1990) . Spec tra were analyzed blindly without knowing the subject status (whether patient or control).
Metabolite concentrations were calculated assuming a cytosolic [ATP] of 3.0 mM, a value found in animal (Chapman et aI., 198 1) and human brain (Bottomly and Hardy, 1989) . We do not have absolute data on ATP con tent in the brain of patients with mitochondrial cytopa thies. Nevertheless, if [ATP] were lower in these pa tients, [ADP] would be even higher.
Mitochondrial functionality was assessed by calculat ing the ADP concentration (Degani et aI., 1987; Petroff et al., 1988) , a major regulator of mitochondrial respiration (Chance and Williams, 1955; Chance et aI., 1986) , the phosphorylation potential (PP), a measure of the readily available free energy in the cell (Veech et aI., 1979) , and the percentage of the maximal rate of ATP biosynthesis (V/V max) (Nioka et aI., 1987) .
Intracellular pH
The intracellular pH was calculated from the chemical shift of inorganic phosphate (Pi) from phosphocreatine (PCr) (Petroff et al., 1984) .
Statistical analysis
Results are presented as mean ± SD. Statistical signif icance was determined using Student's t test for unpaired data. Figure 1 reports a typical 31 P MR spectrum of occipital lobes from a patient (case no. 9) compared with an age-and sex-matched control. A low inten sity of PCr resonance can be seen in the patient's spectrum accompanied by a small increase in Pi res onance. PCr was significantly decreased in all pa tients as shown by Fig. 2 , which reports the distri bution of all cases studied. On the other hand, an increased Pi concentration was not a common find ing in all patients, although the average value of the patient group was significantly (p = 0.009) different from the control group (Table 2 ). An elevated Pi content was found in 14 of 28 patients, the others being within the normal range. The average AOP concentration in the patient group was significantly (p = 0. 000) higher than in the control group (Table 2) , the [AOP] of all patients being higher than the highest value found in normal volunteers (Fig. 2) . AOP is the major regulator of mitochondrial respiration with a K m in the range of 20 fLM (Matthews and Arnold, 1990; Matthews et a1., 1991) . Hence, an increased AOP level shows a defective mitochondrial functionality in all patients. This is also shown by an increased percentile value of the maximal rate of ATP biosynthesis (V/V max ) , and by a decreased PP. The mean value of the PP in 14 patients without any brain symptoms, i.e., 9 with CPEO (cases 1-9) plus 5 with mitochondrial myopathies (cases 19-23), was 57 ± 5.74 (SO), while the mean value of 6 pa tients with LHON and no brain symptoms other than optic neuropathy was 49.5 ± 3.73 (SO). It is also noteworthy that patients no. 24, 25, 26, and 28 with severe brain symptoms had a much lower PP value, i.e., 32, 39, 41, and 34, respectively.
RESULTS
DISCUSSION
Phosphorus MRS to our knowledge is the only noninvasive method that, by direct measurement of high-energy phosphates, affords essential informa tion on the efficiency of A TP production and the extent to which oxidative metabolism meets the bioenergetic needs of cell function. The knowledge of PCr and Pi concentrations enables the calculation of the velocity of oxidative metabolism V in relation to its maximum capability V max according to the Michaelis-Menten relationship, which involves control by ADP and Pi'
We performed brain spectroscopy on occipital lobes in all patients; only two (cases 24 and 26) showed symptoms or signs attributable to the oc cipital cortex. To avoid the contribution of neck and skull skeletal muscles, we checked the profile of the sensitivity volume of the coil when used with the DRESS localization technique by a specifically de signed phantom (Barbiroli et a1., 1991; Keevil et a1. , 1991) . The surface coil was positioned after over lapping the profile of the sensitivity volume of the coil on the proton image of the brain. Contamina tion by muscle resonances was negligible, if any, in our experimental conditions and the signals could be attributed mainly to the brain cortex. Moreover, involvement of neck muscles was not prominent in any of our patients. Despite this, it is conceivable that some muscle contamination, still undetectable by proton imaging, could have occurred, thus af fecting our measurements of the PCr concentration. However, our results were the same in those pa tients who in principle could have atrophy (such as cases 1-12 and 19-23), and in those where the neck muscles were absolutely normal (such as cases 13-18, 24, and 27-28) . Muscle contamination, there fore, did not play any significant role in the quanti tative evaluation of brain PCr in our group of pa tients under our experimental conditions. The concentrations of PCr and Pi in the brain of healthy volunteers were somewhat different from the ones reported by other authors (Eleff et a1., 1990; Matthews et aI., 1991) . The difference can be attributed in part to the different techniques used, in part to different brain areas studied, and in part to the number of lines used to quantify the single res onances of brain spectra (see the Materials and Methods section).
A PCr concentration lower than in matched healthy volunteers was common to all patients. On the other hand, only 14 of 28 patients had an in creased Pi content. However, as the patients with normal Pi content had a low [PCr], the ADP con centration, calculated from the creatine kinase equi librium (Degani et aI., 1987; Petroff et al., 1988) , was also abnormal in all cases (Fig. 2) . It is known from brain studies on animal models that it is pos sible to recognize stable and unstable states of me tabolism by knowing the ADP concentration (Clark et al., 1987; Delivoria-Papadopulos and Chance, 1988) , the relationship between the rate of mito chondrial ATP biosynthesis and [ADP] having the characteristics of a rectangular hyperbola (Chance et al., 1985 (Chance et al., ,1986 . Therefore, an increased cytosolic free [ADP] indicates that the brain tissue operates nearer to the asymptote of the hyperbola and that brain cells are in a more unstable metabolic condi tion.
A derangement of brain energy metabolism in pa tients with abnormal mitochondrial functionality has also been found by Frackowiak et al. (1988) by positron emission tomography (PET), and their re sults are consistent with an increased ADP concen tration.
A defective mitochondrial functionality was also shown in all patients by an increased percent value of V/V max for ATP biosynthesis. Eleff et al. (1990) reported a V/V max of 56% in the brain of normal individuals. We found a V/V max of 55% in our con trol group, while the patient group had a mean of 64%. These findings indicate that the actual rate of ATPase is increased in functioning mitochondria since the ones that have a functional deficit are un able to supply enough ATP to fulfill the energy de mand of the cell. The V/V max values of single pa tients ranged from 59 to 70% (Fig. 2) , a value higher than the highest value found in normal individuals.
All of our patients also showed a decreased cy tosolic PP, an expression of the readily available free energy in the cell (Veech et al., 1979) ; hence, this is another index of mitochondrial functionality in steady-state conditions. The lower the PP, the smaller the energy reserve available in the cell. The PP of patients without any brain symptoms (nine CPEO + six MM) was significantly (p = 0.012) different from the mean value found in six patients with optic neuropathy as the only brain sign (LHON), the mean value of the latter group being 2 SD higher than the single values found in the pa tients with severe brain symptoms. This evidence supports the existence of a relationship between the PP and the severity of brain symptoms. However, at the moment we do not have enough data to draw a definite conclusion on whether brain symptoms in mitochondrial cytopathies depend on the degree of impairment of brain energy metabolism in the dif ferent clinical phenotypes studied.
Our present findings confirm and extend previous results reported by Eleff et al. (1990) and our group (Montagna et al., 1992) that impaired mitochondrial function of brain cortex may be associated with any of the clinical expressions of mitochondrial cytop athies, and that 31p MRS is able to uncover a deficit of brain energy metabolism not only in affected pa tients, but also in those patients without any brain symptoms and/or signs.
